Discussion—Session III, part I

[1]  J. Inui,et al.  Alpha-adrenoceptor-mediated restoration of calcium-dependent potential in the partially depolarized rabbit papillary muscle , 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

[2]  R. Harper,et al.  The acute and chronic haemodynamic effects of prazosin in severe congestive cardiac failure. , 1980, The Medical journal of Australia.

[3]  R. Gorlin,et al.  Dose requirements of hydralazine in patients with severe chronic congestive heart failure. , 1980, The American journal of cardiology.

[4]  R. Gorlin,et al.  Hemodynamic evaluation of hydralazine dosage in refractory heart failure , 1980, Clinical pharmacology and therapeutics.

[5]  R. Gorlin,et al.  Activation of vasoconstrictor mechanisms during vasodilator therapy: A factor modifying drug response in heart failure , 1980 .

[6]  R. Gorlin,et al.  Rebound hemodynamic events after the abrupt withdrawal of nitroprusside in patients with severe chronic heart failure. , 1979, The New England journal of medicine.

[7]  L. Benet,et al.  Attenuation of prazosin effect on cardiac output in chronic heart failure. , 1979, Annals of internal medicine.

[8]  R. Gorlin,et al.  Hemodynamic and Clinical Tachyphylaxisc to Prazosin-Mediated Afterload Reductionin Severe Chronic Congestive Heart Failure , 1979, Circulation.

[9]  W. Grossman,et al.  Nitrate therapy of heart failure in valvular heart disease. Importance of resting level of peripheral vascular resistance in determining cardiac output response. , 1978, The American journal of medicine.

[10]  L. Gould,et al.  Antiarrhythmic Prophylaxis with Phentolamine In Acute Myocardial Infarction , 1975 .